Skip to Content

MYLAN 9 4 (Carbidopa and Levodopa Extended Release 50 mg / 200 mg)

Pill with imprint MYLAN 9 4 is Purple, Elliptical / Oval and has been identified as Carbidopa and Levodopa Extended Release 50 mg / 200 mg. It is supplied by Mylan Pharmaceuticals Inc..

Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 9 4

Carbidopa and levodopa extended release 50 mg / 200 mg MYLAN 9 4
Carbidopa and levodopa extended release 50 mg / 200 mg MYLAN 9 4 Front
Carbidopa and levodopa extended release 50 mg / 200 mg MYLAN 9 4 Back
Carbidopa and levodopa extended release 50 mg / 200 mg MYLAN 9 4

Carbidopa and Levodopa Extended Release

Imprint
MYLAN 9 4
Strength
50 mg / 200 mg
Color
Purple
Size
13.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
FD&C Blue No. 2, FD&C Red No. 40, hydroxypropyl cellulose (type h), hypromelloses, magnesium stearate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-0094 Mylan Pharmaceuticals Inc.
51079-0923 UDL Laboratories Inc.
67544-0672 Prepak Systems Inc. (repackager)

Get help with Imprint Code FAQs.

Related Images for "MYLAN 9 4"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.